JPRN-UMIN000053257招募中Unknown
Discontinuation Criteria for Nucleic Acid Analogues Administered for the Prevention of Hepatitis B Virus Reactivation - Discontinuation Criteria for Nucleic Acid Analogues Administered for the Prevention of HBV Reactivation
agoya City University0 个研究点目标入组 100 人开始时间: 2024年1月4日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who do not meet any of the selection criteria 2)Patients with hematological diseases
研究者
相似试验
进行中（未招募）
1 期
Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B InfectionsEUCTR2021-001003-32-BEAntwerp University Hospital140
进行中（未招募）
1 期
orwegian Nucleoside Analogue Stop Study (Nuc-STOP) - A trial in chronic hepatitis B, aiming at achieving a functional cureHBeAg negative chronic hepatitis BMedDRA version: 20.1 Level: PT Classification code 10052297 Term: Hepatitis B e antigen negative System Organ Class: 10022891 - InvestigationsEUCTR2018-000724-34-SEOslo University Hospital HF130
进行中（未招募）
1 期
Treatment with association of two drugs (Viread and Pegasys) in patients with hepatitis B.Hepatitis B virus (HBV)EUCTR2014-000453-37-ITAzienda Ospedaliera di Padova80
尚未招募
不适用
Can we stop antiviral medicines safely and effectively in patients with chronic hepatitis B and help to increase the chance of cure?Hepatitis BInfection - Other infectious diseasesACTRN12619001441101Dr Tien Huey Lim40
已完成
不适用
Determinants of succesful discontinuation of antipsychotics used for behavioural symptoms in people with intellectual disabilityoff-label useantipsychoticslong-term usebehavioural symptomschallenging behavioursproblem behaviours, intellectual disabilitystaff-related factorsattitudescognitionsknowledgeneurological withdrawal symptomsextrapyramidal symptomsautonomic symptomsquality of lifeNL-OMON21589niversity Medical Centre Groningen/department psychiatry200